Animal models for elucidating human disease: Confronting cancer and other chronic diseases

CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources

Volumn 4, Issue , 2009, Pages

  Kuzmuk, Kristy N ^a   Schook, Lawrence B ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Animal model; Biotechnology; Chronic disease; Transgenic animal model

Indexed keywords

ANIMALIA; CANIS FAMILIARIS; MAMMALIA; MUS; SUIDAE;

EID: 70449499906     PISSN: None     EISSN: 17498848     Source Type: Journal    
DOI: 10.1079/PAVSNNR20094032     Document Type: Review

References (59)

1. Tejada-Vera B, Sutton PD. Births, marriages, divorces, and deaths: provisional data for June 2008. In: National Vital Statistics Reports, volume 57, No.11. National Center for Health Statistics, Hyattsville, MD; 2009. p. 1.
2. Swanson KS, Mazur MJ, Vashisht K, Rund LA, Beever JE, Counter CM, et al. Genomics and clinical medicine: rationale for creating and effectively evaluating animal models. Experimental Biology and Medicine 2004;229:866-875
3. Pantelouris EM. Absence of thymus in a mouse mutant. Nature 1968;217(5126):370-371
4. Waters DJ, Sakr WA, Hayden DW, Lang CM, McKinney L, Murphy GP, et al. Workgroup 4: spontaneous prostate carcinoma in dogs and nonhuman primates. Prostate 1998;36(1):64-67
5. Vincent-Naulleau S, Le Chalony C, Leplat JJ, Bouet S, Bailly C, Spatz A, et al. Clinical and histopathological characterization of cutaneous melanomas in the melanoblastoma-bearing Libechov minipig model. Pigment Cell Research 2004;17(1):24-35.
6. Oxenhandler RW, Berkelhammer J, Smith GD, Hook Jr RR. Growth and regression of cutaneous melanomas in sinclair miniature swine. American Journal of Pathology 1982;109(3):259-269
7. Pathak S, Multani AS, McConkey DJ, Imam AS, Amoss Jr MS. Spontaneous regression of cutaneous melanoma in sinclair swine is associated with defective telomerase activity and extensive telomere erosion. International Journal of Oncology 2000;17(6):1219-1224
8. Perez J, García PM, Bautista MJ, Millán Y, Ordás J, Martín de las Mulas J. Immunohistochemical characterization of tumor cells and inflammatory infiltrate associated with cutaneous melanocytic tumors of Duroc and Iberian swine. Veterinary Pathology 2002;39(4):445-451
9. Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Cory S, et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 1985;318:533-538
10. Brinster RL, Chen HY, Messing A, Van Dyke T, Levine AJ, Palmiter RD. Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell 1984;37:367-379
11. Hanahan D. Transgenic mice as probes into complex systems. Nature 1989;246:1265-1275
12. Stewart TA, Pattengale K, Leder P. Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes. Cell 1984;38:627-637
13. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proceedings of the National Academy of Sciences, USA 1992;89:5547-5551
14. O'Gorman S, Fox DT, Wahl GM. Recombinase-mediated gene activation and site-specific integration in mammalian cells. Science 1991;251:1351-1355
15. Sauer B, Henderson N. Cre-stimulated recombination at loxP containing DNA sequences placed into the mammalian genome. Nucleic Acid Research 1989;17:147-161
16. Yu J, McMahon AP. Reproducible and inducible knockdown of gene expression in mice. Genesis 2006;44:252-261
17. Seibler J, Kleinridders A, Kuter-Luks B, Niehaves S, Bruning JC, Schwenk F. Reversible gene knockdown in mice using a tight, inducible shRNA expression system. Nucleic Acids Research 2007;35:e54.
18. Shultz LD, Ishikawa F, Greiner DL. Humanized mice in translational biomedical research. Nature Reviews, Immunology 2007;7:118-130
19. Smithies O. Animal models of human genetic diseases. Trends in Genetics 1993;9:112-116
20. Rosenberg MP, Bortner D. Why transgenic and knockout animal models should be used for drug efficacy studies in cancer. Cancer Metastasis Reviews 1999;17:295-299
21. Yamagiwa K, Ichikawa K. Experimental study of the pathogenesis of carcinoma. Cancer Research 1918;3:1-29.
22. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
23. Land H, Parada LF, Weinberg RA. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 1983;304:596-602.
24. Ruley HE. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature 1983;304:602-606
25. Stevenson M, Volsky DJ. Activated v-myc and c-myc oncogenes do not transform normal human lymphocytes. Molecular and Cellular Biology 1986;6:3410-3417
26. Sager R, Tanaka K, Lau CC, Ebina Y, Anisowicz A. Resistance of human cells to tumorigenesis induced by cloned transforming genes. Proceedings of the National Academy of Sciences, USA 1983;80:7601-7605
27. O'Brien W, Steinman G, Sager R. Suppression of tumor growth by senescence in virally transformed human fibroblasts. Proceedings of the National Academy of Sciences, USA 1986;83:8659-8663
28. Akagi TH, Hanafusa H. Human diploid fibroblasts are refractory to oncogene-mediated transformation. Cell Cycle 2004;3:257-258
29. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. Creation of human tumour cells with defined genetic elements. Nature 1999;400:464-468
30. O'Hayer KM, Counter CM. A genetically defined normal somatic human cell system to study ras oncogenesis in vitro and in vivo. In: Balch WE, Der CJ, Hall A, editors. Regulators and Effectors of Small GTPases: Ras Family. Academic Press, San Diego, CA; 2006. p. 637-647
31. Naito S, Giavazzi R, Walker SM, Itoh K, Mayo J, Fidler IJ. Growth and metastatic behavior of human tumor cells implanted into nude and beige nude mice. Clinical and Experimental Metastasis 1987;5:135-146
32. Corbett TH, Polin L, Roberts BJ, Lawson AJ, Leopold III WR, White K, et al. Transplantable syngeneic rodent tumors: solid tumors in mice. In: Teicher B, editor. Tumor Models in Cancer Research. Humana Press, Totowa, NJ; 2002. p. 41-72.
33. Averbook B, Schuh JCL, Papay R, Maliszewski C. Antitumor effects of flt3 ligand in transplanted murine tumor models. Journal of Immunotherapy 2002;25:27-35.
34. Gershwin ME, Ikeda RM, Kawakami TG, Owens RB. Immunobiology of heterotransplanted human tumors in nude mice. Journal of the National Cancer Institute 1977;58:1455-1460
35. Eccles SA. Models for evaluation of targeted therapies of metastatic disease. In: Teicher B, editor. Tumor Models in Cancer Research. Humana Press, Totowa, NJ; 2002. p. 293-322.
36. Becher OJ, Holland EC. Genetically engineered models have advantages over xenografts for preclincial studies. Cancer Research 2006;66(7):3355-3359
37. Adam SJ, Rund LA, Kuzmuk KN, Zachary JF, Schook LB, Counter CM. Genetic induction of tumorigenesis in swine. Oncogene 2007;26(7):1038-1045
38. Petropoulos CJ, Hughes SH. Replication competent retrovirus vectors for the transfer and expression of gene cassettes in avian cells. Journal of Virology 1991;65:3728-3737
39. Bates P, Young JA, Varmus HE. A receptor for subgroup A Rous sarcoma virus is related to the low density lipoprotein receptor. Cell 1993;74:1043-1051
40. Fisher GH, Orsulic S, Holland E, Hively WP, Li Y, Lewis BC, et al. Development of a flexible and specific gene delivery system for production of murine tumor models. Oncogene 1999;18:5253-5260
41. Hau J. Animal models for human disease: an overview. In: Conn MP, editor. Sourcebook of Models for Biomedical Research. Humana Press, Totowa, NJ; 2008. p. 3-8.
42. Cui Z, Willingham MC, Hicks AM, Alexander-Miller MA, Howard TD, Hawkins GA, et al. Spontaneous regression of advanced cancer: identification of a unique genetically determined, age-dependent trait in mice. Proceedings of the National Academy of Sciences, USA 2003;100(11):6682-6687
43. Beasley GM, Kahn L, Tyler DS. Current clinical and research approaches to optimizing regional chemotherapy: novel strategies generated through a better understanding of drug pharmacokinetics, drug resistance, and the development of clinically relevant animal models. Surgical Oncology Clinics of North America 2008;14(4):731-758, vii-viii.
44. Olsen RG, Mathes LE, Hebebrand LC, Hoover EA, Nichols WS. Animal model: feline leukemia virus disease. American Journal of Pathology 1980;98(3):857-860
45. Tumbleson ME, Schook LB. Advances in Swine in Biomedical Research. Plenum Press, New York; 1996.
46. Swindle MM, Smith AC. Information Resources on Swine in Biomedical Research 1990-2000. National Agricultural Library; 2000. Available from: URL: http://www.nal.usda.gov/awic/pubs/swine/swine.htm (retrieved 18 February 2009).
47. Thomas JW, Touchman JW, Blakesley RW, Bouffard GG, Beckstrom-Sternberg SM, Margulies EH, et al. Comparative analyses of multi-species sequences from targeted genomic regions. Nature 2003;424:788-793
48. Olson H, Betton G, Robinson D, Thomas K, Monro A, Kolaja G, et al. Concordance of the toxicity of pharmaceuticals in humans and in animals. Regulatory Toxicology and Pharmacology 2000;32:56-67.
49. Xie W, Evans RM. Pharmaceutical use of mouse models humanized for the xenobiotic receptor. Drug Discovery Today 2002;7(9):509-515
50. Pollock CB, Rogatcheva MB, Schook LB. Comparative genomics of xenobiotic metabolism: a porcine-human PXR gene comparison. Mammalian Genome 2007;18(3):210-219
51. Anderson LJ, Jarrett WF. Lymphosarcoma (leukemia) in cattle, sheep and pigs in Great Britain. Cancer 1968;22(2):398-405.
52. Brown DG, Johnson DF. Diseases of aged swine. Journal of the American Veterinary Medical Association 1970;157(11):1914-1918
53. Stewart SA, Weinberg RA. Telomerase and human tumorigenesis. Seminars in Cancer Biology 2000;10(6):399-406.
54. Hau J, Van Hoosier GL. Handbook of Laboratory Animal Science. CRC Press, Boca Raton, FL; 2003.
55. Kornetsky C. Animal models: promises and problems. In: Hanin I, Usdin E, editors. Animal Models in Psychiatry and Neurology. Pergamon Press, Oxford, UK; 1977. p. 1-8.
56. Willner P. Validation criteria for animal models of human mental disorders: learned helplessness as a paradigm case. Progress in Neuro-Psycopharmacology and Biological Psychiatry 1986;10:677-690
57. Morgenson J, Holm S. Basic research and animal models in neuroscience: the necessity of co-evolution. Scandinavian Journal of Laboratory Animal Science 1989;16:51.
58. Sagvolden T, Russel VA, Aase H, Johansen EB, Farshbaf M. Rodent models of attention-deficit/hyperactivity disorder. Biological Psychiatry 2005;57:1239-1247
59. Hann B, Balmain A. Building 'validated' mouse models of human cancers. Current Opinion in Cell Biology 2001;13:778-784